Pinar Siyah

Dr. Pinar Siyah

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TGTuğba Güngör
Tuğba Güngör
Adem OzleyenAdem Ozleyen
Adem Ozleyen
YYYakup Berkay Yılmaz
Yakup Berkay Yılmaz
PSPinar Siyah
Pinar Siyah
MAMehmet Ay
Mehmet Ay
TTTugba Boyunegmez Tumer
Tugba Boyunegmez Tumer

6 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NSNermin Basak Sentürk
Nermin Basak Sentürk
BKBurcu Kasapoglu
Burcu Kasapoglu
ESEray Sahin
Eray Sahin
Orhan ÖzcanOrhan Özcan
Orhan Özcan
MOMehmet Ozansoy
Mehmet Ozansoy
FSFikrettin Sahin
Fikrettin Sahin
Background/Objectives: The role of the gut microbiome in the development and progression of many diseases has received increased attention in recent years. Boron, a trace mineral found in dietary sources, has attracted interest due to its unique electron depletion and coordination characteristics in chemistry, as well as its potential role in modulating the gut microbiota. This study investigates the effects of inorganic boron derivatives on the gut microbiota of mice. Methods: For three weeks, boric acid (BA), sodium pentaborate pentahydrate (NaB), and sodium perborate tetrahydrate (SPT) were dissolved (200 mg/kg each) in drinking water and administered to wild-type BALB/c mice. The composition of the gut microbiota was analyzed to determine the impact of these treatments. Results: The administration of BA significantly altered the composition of the gut microbiota, resulting in a rise in advantageous species such as Barnesiella and Alistipes. Additionally, there was a decrease in some taxa associated with inflammation and illness, such as Clostridium XIVb and Bilophila. Notable increases in genera like Treponema and Catellicoccus were observed, suggesting the potential of boron compounds to enrich microbial communities with unique metabolic functions. Conclusions: These findings indicate that boron compounds may have the potential to influence gut microbiota composition positively, offering potential prebiotic effects. Further research with additional analyses is necessary to fully understand the interaction between boron and microbiota and to explore the possibility of their use as prebiotic agents in clinical settings.

23 September 2021 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
PSPinar Siyah
Pinar Siyah
SASezer Akgol
Sezer Akgol
SDSerdar Durdagi
Serdar Durdagi
FKFatih Kocabas
Fatih Kocabas
OTU proteases antagonize the cellular defense in the host cells and involve in pathogenesis. Intriguingly, P. falciparum, P. vivax, and P. yoelii have an uncharacterized and highly conserved viral OTU-like proteins. However, their structure, function or inhibitors have not been previously reported. To this end, we have performed structural modeling, small molecule screening, deconjugation assays to characterize and develop first-in-class inhibitors of P. falciparum, P. vivax, and P. yoelii OTU-like proteins. These Plasmodium OTU-like proteins have highly conserved residues in the catalytic and inhibition pockets similar to viral OTU proteins. Plasmodium OTU proteins demonstrated Ubiquitin and ISG15 deconjugation activities as evident by intracellular ubiquitinated protein content analyzed by western blot and flow cytometry. We screened a library of small molecules to determine plasmodium OTU inhibitors with potent anti-malarial activity. Enrichment and correlation studies identified structurally similar molecules. We have identified two small molecules that inhibit P. falciparum, P. vivax, and P. yoelii OTU proteins (IC50 values as low as 30nM) with potent anti-malarial activity (IC50 of 4.1-6.5 μM). We also established enzyme kinetics, druglikeness, ADME, and QSAR model. MD simulations allowed us to resolve how inhibitors interacted with plasmodium OTU proteins. These findings suggest that targeting malarial OTU-like proteases is a plausible strategy to develop new anti-malarial therapies.

9 August 2024 in Cancer Medicine
Verified
Journal Article
Open access
FBFırat Barış BARLAS
Fırat Barış BARLAS
BOBilge Olceroglu
Bilge Olceroglu
DSDidem Ag Seleci
Didem Ag Seleci
ZGZinar Pinar Gumus
Zinar Pinar Gumus
PSPinar Siyah
Pinar Siyah
STSuna Timur
Suna Timur
Background: Cancer remains a formidable global health challenge, currently affecting nearly 20 million individuals worldwide. Due to the absence of universally effective treatments, ongoing research explores diverse strategies to combat this disease. Recent efforts have concentrated on developing combined drug regimens and targeted therapeutic approaches.Objective: This study aimed to investigate the anticancer efficacy of a conjugated drug system, consisting of doxorubicin and cisplatin (Dox‐Cis), encapsulated within niosomes and modified with MUC‐1 aptamers to enhance biocompatibility and target specific cancer cells.Methods: The chemical structure of the Dox‐Cis conjugate was characterized using Fourier Transform Infrared Spectroscopy (FTIR) and Liquid Chromatography Quadrupole Time‐of‐Flight Mass Spectrometry (LC‐Q‐TOF/MS). The zeta potential and morphological parameters of the niosomal vesicles were determined through Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM). In vitro assessments of cell viability and apoptosis were conducted on MUC‐1 positive HeLa cells and MUC‐1 negative U87 cells.Results: The findings confirmed the successful conjugation of Dox and Cis within the niosomes. The Nio/Dox‐Cis/MUC‐1 formulation demonstrated enhanced efficacy compared to the individual drugs and their unencapsulated combination in both cell lines. Notably, the Nio/Dox‐Cis/MUC‐1 formulation exhibited greater effectiveness on HeLa cells (38.503 ± 1.407) than on U87 cells (46.653 ± 1.297).Conclusion: The study underscores the potential of the Dox‐Cis conjugate as a promising strategy for cancer treatment, particularly through platforms that facilitate targeted drug delivery to cancer cells. This targeted approach could lead to more effective and personalized cancer therapies.

4 October 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
SKSERDAR KARAKURT
SERDAR KARAKURT
HBHatice Gül Batur
Hatice Gül Batur
KBKemal Bas
Kemal Bas
PSPinar Siyah
Pinar Siyah

24 October 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YYYakup Berkay Yilmaz
Yakup Berkay Yilmaz
TGTuğba Güngör
Tuğba Güngör
SDSerhat Dönmez
Serhat Dönmez
HAHazal Nazlıcan Atalay
Hazal Nazlıcan Atalay
PSPinar Siyah
Pinar Siyah
TTTugba Boyunegmez Tumer
Tugba Boyunegmez Tumer
New isothiocyanate derivatives (I1–3 and I1a–e) were synthesized and screened for their anti-inflammatory activities and H 2 S-releasing capacities. Compounds I1 and I1c demonstrated the most potent and selective COX-2 inhibition.